✦ LIBER ✦

Do urinary MHPG and plasma drug levels correlate with response to amitriptyline therapy?

✍ Scribed by Hans J. Gaertner; Franz Kreuter; Günther Scharek; Gerlinde Wiatr; Ursula Breyer-Pfaff

Publisher: Springer
Year: 1982
Tongue: English
Weight: 480 KB
Volume: 76
Category: Article
ISSN: 0033-3158
DOI: 10.1007/bf00432552

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Raised plasma kininogen levels in rheuma

Raised plasma kininogen levels in rheumatoid patients—Response to therapy with nonsteroidal anti-inflammatory drugs

✍ I. J. Zeitlin; J. N. Sharma; P. M. Brooks; W. C. Dick 📂 Article 📅 1976 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 112 KB

Inverse correlation between clinical res

Inverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disorders

✍ Norio Yasui-Furukori; Taku Nakagami; Ayako Kaneda; Yoshimasa Inoue; Akihito Suzu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 1 views

## Objective There are few data concerning a clear relationship between the clinical effect of paroxetine and plasma drug concentrations, although therapeutic ranges have been established for some tricyclic antidepressants. ## Methods In this study, 120 patients with major depressive disorders we

Plasma Homovanillic Acid Level in Drug f

Plasma Homovanillic Acid Level in Drug free Patients with Nonorganic Psychotic Disorders and Subsequent Response to Neuroleptics

✍ S. YAMADA; J. NAKAMURA; N. UCHIMURA; I. SHIRAO; I. NOSE; N. MATSUGUCHI; H. TAKAG 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

Cytogenetic and molecular responses to s

Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels

✍ Donna L. Forrest; Shannon Trainor; Ryan R. Brinkman; Michael J. Barnett; Donna E 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Pretreatment plasma intact parathyroid h

Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism

✍ Yuko Oyama; Junichiro James Kazama; Kentaro Omori; Noboru Higuchi; Shigemi Kamed 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 311 KB

Effects of SREBF-1a and SCAP polymorphis

Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatin

✍ Lorraine Salek; Silvia Lutucuta; Christie M. Ballantyne; Antonio M. Gotto; A. Ma 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 212 KB